EHealth Based Self-management Intervention for Chronic Kidney Disease Care in China

Interventions that support disease self-management (further referred to as 'self-management interventions') can have a significant impact on the health and quality of life of patients suffering from chronic conditions in general and chronic kidney disease (CKD) patients in specific. In the last decade, the use of electronic health (eHealth) technology in self-management interventions has become more and more popular. EHealth-based self-management interventions have been shown to improve health-related outcomes, such as blood pressure (BP) control and medication adherence, and found to be feasible and acceptable for CKD patients and care professionals. Hence, the use of eHealth self-management interventions for CKD patients has become increasingly popular. Knowledge of the implementation and effectivity of such interventions in China and other developing countries is, however, still lacking. Researchers from the Leiden University Medical Center (LUMC) developed 'Medical Dashboard', an eHealth intervention to help support and involve CKD patients in their disease self-management. We aim to tailor the evidence-based Dutch intervention 'Medical Dashboard' to the Chinese context and evaluate its implementation process and effectiveness.

• Change of blood pressure from baseline to 3, 6 and 9 months after randomization [Срок оценки: 0 month (baseline), 3 months after randomisation, 6 months after randomisation, 9 months after randomisation (endpoint)]
• Change of body weight from baseline to 3, 6 and 9 months after randomization [Срок оценки: 0 month (baseline), 3 months after randomization, 6 months after randomization, 9 months after randomization (endpoint)]
• Change of glomerular filtration rate from baseline to 3, 6 and 9 months after randomization [Срок оценки: 0 month (baseline), 3 months after randomisation, 6 months after randomisation, 9 months after randomisation (endpoint)]
• Change of serum albumin from baseline to 3, 6 and 9 months after randomization [Срок оценки: 0 month (baseline), 3 months after randomisation, 6 months after randomisation, 9 months after randomisation (endpoint)]
• Change of serum creatinine from baseline to 3, 6 and 9 months after randomization [Срок оценки: 0 month (baseline), 3 months after randomisation, 6 months after randomisation, 9 months after randomisation (endpoint)]
• Change of number of complications patients have from baseline to 3, 6 and 9 months after randomization [Срок оценки: 0 month (baseline), 3 months after randomisation, 6 months after randomisation, 9 months after randomisation (endpoint)]
• Change of chronic kidney disease self-efficacy using Chronic Kidney Disease Self-efficacy (CKD-SE) scale from baseline to 3, 6 and 9 months after randomization [Срок оценки: 0 month (baseline), 3 months after randomisation, 6 months after randomisation, 9 months after randomisation (endpoint)]
• Change of chronic kidney disease illness perception using Brief Illness Perception Questionnaire (BIPQ) from baseline to 9 months after randomization [Срок оценки: 0 month (baseline), 9 months after randomisation (endpoint)]
• Change of chronic kidney disease anxiety and depression status using the Hospital Anxiety and Depression Scale (HADS) from baseline to 3, and 9 months after randomization [Срок оценки: 0 month (baseline), 3 months after randomisation, 9 months after randomisation (endpoint)]
• Change of chronic kidney disease quality of life using the Kidney Disease Quality of Life 36-item short-form survey (KDQOL-36) from baseline to 9 months after randomization [Срок оценки: 0 month (baseline), 9 months after randomisation (endpoint)]
• Hospital admission [Срок оценки: 9 months after randomisation (endpoint)]
• Change of healthcare utilisation from 3 months after randomisation to 9 months after randomisation [Срок оценки: 3 months after randomisation, 9 months after randomisation (endpoint)]